Navigation Links
Omada Program Launches Preferred Devices to Monitor Blood Sugar, Blood Pressure
Date:3/12/2019

Omada Health today announced the inclusion and integration of FDA-cleared, cellular-connected blood pressure cuffs and glucometers for qualifying participants in the company’s chronic condition management program. The integration of these devices will enable individuals to seamlessly upload real-time readings to their Omada account, while providing Omada coaches insight to deliver personalized guidance and ongoing support as participants work to improve their health.

Building on the company’s pioneering approach to sustainable behavior change, Omada will make glucometers and blood pressure cuffs available to any participants clinically recommended to self-monitor blood pressure and glucose levels. Participants who receive the Omada preferred glucometer will also receive as many free test strips as needed. Readings from the devices will be automatically uploaded to a participant’s account, enabling his or her coach to deliver personalized recommendations informed by a wide range of data, and the deep relationship forged with each individual. Participants will also be able to view readings in their account, and track progress over time. The Omada program will also continue to support a ‘bring your own device model’ for participants and customers that prefer the option.

“Our approach - at all levels of our program -- is to provide a unique flexibility that matches the unique circumstances of our participants, while always following clinical best practices,” said Omada VP of Medical Affairs Carolyn Bradner Jasik, MD. “Participants in the Omada program build deep relationships with their coaches; enabling automatic cellular uploading of glucose and blood pressure data will enable those coaches to provide guidance informed by a wide range of data and insights -- helping support the best possible health outcomes.”

When combined with clinical support, self-monitoring of blood pressure improves control, as well as the quality and accessibility of care for people with hypertension. The Centers for Disease Control and Prevention recommends self-monitoring of blood pressure, with similar guidance also coming from the American Medical Association, the American Heart Association, and the American Society of Hypertension. Omada will follow the American Diabetes Association Standards of Care to determine individual eligibility for the cellular glucose monitor.

“At Omada, we follow clinical best practices while delivering excellent participant and customer experiences,” said Sean Duffy, CEO of Omada Health. “Since Day 1, Omada’s program has put the needs of users at its center while driving value for our customers, and the U.S. healthcare system. Our device strategy maintains that focus, and we’re proud to be following the best clinical guidelines in doing so.”

About Omada Health

Omada is a digital behavioral medicine company focused on reducing costly chronic disease in employer and health plan populations. The company offers a personalized intervention for individuals at risk for, or with, obesity-related chronic conditions such as type 2 diabetes and hypertension. Omada is the largest CDC-recognized provider of the National Diabetes Prevention Program, with deep integration experience with leading health plans, outcomes-based pricing, and eleven peer-reviewed studies demonstrating the company’s ability to deliver lasting, clinically-meaningful results. To learn more, visit http://www.omadahealth.com.

Read the full story at https://www.prweb.com/releases/omada_program_launches_preferred_devices_to_monitor_blood_sugar_blood_pressure/prweb16161946.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Omada Health Completes SOC 2 Type II Audit
2. North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program
3. Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog
4. Omeros Files Clinical Trial Application for Lead Antibody in MASP-2 Program
5. PDR Network and OPTIMIZERx (SampleMD) Announce Partnership to Deliver Patient Financial Support Programs Within EHR Workflow
6. Global Role of Market Research Supports Need for Training and Development Programs
7. Prime Therapeutics appoints Scott Fries as senior vice president of government programs
8. Rigel Will Resume Responsibility for Fostamatinib Program
9. Tunitas Therapeutics Awarded Phase II SBIR Grant to Advance Asthma Program
10. UBM Canon Celebrates the 30th Anniversary of MD&M East, the East Coasts Largest Medical OEM Event, and the 15th Anniversary of the Medical Design Excellence Awards, the MedTech Industrys Premier Awards Program
11. Romanoff Joins Innovative Statewide Program to Combat Abuse of Prescription Pain Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2019)... ... 2019 , ... Lillibridge Healthcare Services Inc., a wholly owned ... operators of medical office buildings (MOBs), will sponsor and host three educational sessions ... Managers Association (BOMA) International Medical Office Buildings + Healthcare Facilities Conference May 1-3 ...
(Date:4/17/2019)... Mass. (PRWEB) , ... April ... ... (CST), a leading provider of antibodies, kits, and services, today announced that ... strengthen CST’s alignment with organizations that encourage science and environmental education, arts, ...
(Date:4/17/2019)... ... ... Clinical trials of new cancer treatments have historically focused on disease type by tumor ... oncology and genomic characterization of tumors, we are now able to test new therapies ... ability has created a paradigm shift in oncology trials. , In basket trials, cancers ...
Breaking Medicine Technology:
(Date:4/19/2019)... ... 19, 2019 , ... Elohi Strategic Advisors is proud to ... From plant-based proteins to herbal tonics, gluten-free pastas to Keto-friendly sweeteners, these brands ... • Field Roast, a Seattle-based company, is the original maker of grain ...
(Date:4/18/2019)... and DANVERS, Mass. (PRWEB) , ... April 18, ... ... radiotherapy and proton therapy, with the ability to deliver targeted radiation to cancer ... the nuclear reactor in traditional BNCT research platforms. Engineered from the ground up ...
(Date:4/18/2019)... ... April 18, 2019 , ... Governor Phil ... of areas. This year’s bill proposed several updates to Vermont’s leading captive law, ... group captive investments. The many enhancements included in this year’s bill highlight the ...
(Date:4/18/2019)... ... ... The Coro Medical official sweepstakes grand prize winner of the LIFEPAK 15 ... small, volunteer-only department in rural Mississippi, Livingston entered the national contest with the hopes ... with life-saving equipment of this caliber in Panola County. , “We are so excited ...
(Date:4/17/2019)... ... April 17, 2019 , ... With Fentanyl overdose deaths ... working to curb the death toll by looking for an alternative to naloxone. Researchers ... Meeting & Exposition this week. , Naloxone (often known by the name brand Narcan) ...
Breaking Medicine News(10 mins):